Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site

Nucleic Acids Research

Volumn 36, Issue 9, 2008, Pages 2969-2980

  Kirschner, Ralf D ^a   Sänger, Katja ^a   Müller, Gerd A ^a   Engeland, Kurt ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; INITIATION FACTOR; ISOPROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P63 GAMMA; PROTEIN P73; PROTEIN S 100; PROTEIN S 100A2; TUMOR SUPPRESSOR PROTEIN;

ACRO DERMATO UNGUAL LACRIMAL TOOTH SYNDROME; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL DIFFERENTIATION; CONGENITAL SKIN DISEASE; CONTROLLED STUDY; DNA BINDING MOTIF; DNA DAMAGE; EEC SYNDROME; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; MUTANT; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA SPLICING; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ABNORMALITIES, MULTIPLE; BINDING SITES; CELL LINE; CHEMOTACTIC FACTORS; DNA DAMAGE; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; MUTATION; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; RNA, MESSENGER; S100 PROTEINS; SYNDROME; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 44349086038     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn132     Document Type: Article

References (62)

1. Glenney,J.R., Kindy,M.S. and Zokas,L. (1989) Isolation of a new member of the S100 protein family - amino-acid sequence, tissue and subcellular-distribution. J. Cell Biol., 108, 569-578.
2. Boni,R., Burg,G., Doguoglu,A., Hg,E.C., Schafer,B.W., Muller,B. and Heizmann,C.W. (1997) Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br. J. Dermatol., 137, 39-43.
3. Lapi,E., Iovino,A., Fontemaggi,G., Soliera,A.R., Iacovelli,S., Sacchi,A., Rechavi,G., Givol,D., Blandino,G. and Strano,S. (2006) S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. Oncogene, 25, 3628-3637.
4. Mandinova,A., Atar,D., Schafer,B.W., Spiess,M., Aebi,U. and Heizmann,C.W. (1998) Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci., 111, 2043-2054.
5. Mueller,A., Bachi,T., Hochli,M., Schafer,B.W. and Heizmann,C.W. (1999) Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation. Histochem. Cell Biol. 111, 453-459.
6. Zhang,T., Woods,T.L. and Elder,J.T. (2002) Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized. and malignant human keratinocytes. J. Invest. Dermatol., 119, 1196-1201.
7. Nakayama.S. and Kretsinger,R.H. (1994) Evolution of the Ef-hand family of proteins. Annu. Rev. Biophys, Biomol. Struct., 23, 473-507.
8. Deshpande,R. Woods,T.L. Fu,J., Zhang,T., Stoll,S.W. and Elder,J.T. (2000) Biochemical characterization of S100A2 in human keratinocytes: Subcellular localization, dimerization, and oxidative cross-linking. J. Invest. Dermatol., 115, 477-485.
9. Franz,C., Durussel,I., Cox,J.A., Schafer,B.W. and Heizmann,C.W. (1998) Binding of Ca2+ and Zn2+ to human nuclear S100A2 and mutant proteins. J. Biol. Chem., 273, 18826-18834.
10. Marenholz,I., Heimann,C.W. and Fritz,G. (2004) S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun., 322, 1111-1122.
11. Volz,A., Korge,B.P., Compton,J.G., Ziegler,A., Steinert,P.M. and Mischke,D. (1993) Physical mapping of a functional cluster of epidermal differentiation genes on chromosome-IQ21. Genomics, 18, 92-99.
12. Zimmer,D.B., Cornwall,E.H., Landar,A. and Song,W. (1995) The S100 protein family - history, function, and expression. Brain Res. Bull. 37, 417-429.
13. Donato,R. (2003) Intracellular and extracellular roles of s100 proteins. Microsc. Res. Tech., 60, 540-551.
14. Lee,S.W., Tomasetto,C. and Sager,R. (1991) Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc. Natl Acad. Sci. USA, 88, 2825-2829.
15. Feng,G., Xu,X.C., Youssef,E.M. and Lotan,R. (2001) Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res., 61, 7999-8004.
16. Lee,S.W., Tomasetto,C., Swisshelm,K., Keyomarsi,K. and Sager,R. (1992) Down-regulation of a member of the S100 gene family in mammary-carcinoma cells and reexpression by azadeoxycytidine treatment. Proc. Natl Acad. Sci. USA, 89, 2504-2508.
17. Maelandsmo,G.M., Florenes,V.A., Mellingsaeter,T., Hovig,F., Kerbel,R.S. and Fodstad,O. (1997) Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int. J. Cancer, 74, 464-469.
18. Zhang,X., Hunt,J.T., Shin,D.M. and Chen,Z.G. (2006). Down-regulation of S100A2 in lymph node metastases of head and neck cancer. Head Neck 29, 236-243.
19. Wicki,R., Franz,C., Scholl,F.A., Heizmann,C.W. and Schafer,B.W. (1997) Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site specific hypermethylation. Cell Calcium 22, 243-254.
20. Tan,M., Heizmann,C.W., Guan,K., Schafer,B.W. and Sun,Y. (1999) Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett., 445, 265-268.
21. El Rifai,W., Moskaluk,C.A., Abdrabbo,M.K., Harper,J., Yoshida,C., Riggins,G.J., Frierson,H.F. and Powell,S.M. (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res., 62, 6823-6826.
22. Hough,C.D., Cho,K.R., Zonderman,A.B., Schwartz,D.R. and Morin,P.J. (2001) Coordinately up-regulated genes in ovarian cancer. Cancer Res. 61, 3869-3876.
23. Hsieh,H.L., Schafer,B.W., Sasaki,N. and Heizmann,C.W. (2003) Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res. Commun., 307, 375-381.
24. Lauriola,L., Michetti,F., Maggiano,N., Galli,J., Cadoni,G., Schafer,B.W., Heizmann,C.W. and Ranelletti,F.O. (2000) Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma. Int. J. Cnacer, 89, 345-349.
25. Nagy,N., Brenner,C., Markadieu,N., Chaboteaux,C., Camby,I., Schafer,B.W., Pochet,K., Heizmann,C.W., Salmon,I., Kiss,R. et al. (2001) S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. Lab. Invest., 81, 599-612.
26. Wang,H., Zhang,Z., Li,R., Ang,K.K., Zhang,H., Caraway,N.P., Katz,K.L. and Jiang,F. (2005) Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int. J. Cancer, 116, 285-290.
27. Mueller,A., Schafer,B.W., Ferrari,S., Weibel,M., Makek,M., Hochli,M. and Heizmann,C.W. (2005) The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J. Biol. Chem., 280, 29186-29193.
28. Tsai,W.C., Tsai,S.T., Jin,Y.T. and Wu,L.W. (2006) Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Mol. Cancer Res., 4, 539-547.
29. Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C. (2006) p53/p63/p73 isoforms: An orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death. Differ., 13, 962-972.
30. Schmale,H. and Bamberger,C. (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene, 15, 1363-1367.
31. Senoo,M., Seki,N., Ohira,M., Sugano,S., Watanabe,M., Tachibana,M., Tanaka,T., Shinkai,Y. and Kato,H. (1998) A second p53-related protein, p73L, with high homology to p73. Biochem. Biophys. Res. Commun., 248, 603-607.
32. Trink,B., Okami,K., Wu,L., Sriuranpong,V., Jen,J. and Sidransky,D. (1998) A new human p53 homologue. Nat. Med., 4, 747-748.
33. Yang,A., Kaghad,M., Wang,Y., Gillett,E., Fleming,M.D., Dotsch,V., Andrews,N.C., Caput,D. and McKeon,F. (1998) p63, a p53 homolog at 3q27-29, encodes myltiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2, 305-16.
34. Flores,E.R., Tsai,K.Y., Crowley,D., Sengupta,S., Yang,A., McKeon,F. and Jacks,T. (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature, 416, 560-564.
35. Brunner,H.G., Hamel,B.C. and van Bokhoven,H. (2002) The p63 gene in EEC and other syndromes. J. Med. Genet., 39, 377-381.
36. Mills,A.A., Zheng,B., Wang,X.J., Vogel,H., Roop,D.R. and Bradley,A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
37. Rinne,T., Hamel,B., van Bokhoven,H. and Brunner,H.G. (2006) Pattern of p63 mutations and their phenotypes update. Am. J. Med. Genet. A, 140, 1396-1406
38. van Bokhoven,H., Hamel,B.C., Bamshad,M., Sangiorgi,E., Gurrieri,F., Duijf,P.H., Vanmolkot,K.R. van Beusekom,E., van Beersum,S.F., Celli,J. et al. (2001) p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Genet., 69, 481-492.
39. van Bokhoven,H. and McKeon,F. (2002) Mutations in the p53 homolog p63: allele-specific developmental sydrome in humans. Trends Mol. Med., 8, 133-139.
40. Yang,A., Schweitzer,R., Sun,D., Kaghad,M., Walker,N., Bronson,R.T., Tabin,C., Sharpe,A., Caput,D., Crum,C. et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and enithelial development. Nature, 398, 714-718.
41. Yang,A. and McKeon,F. (2000) P63 and P73: P53 mimics, menaces and more. Nat. Rev. Mol. Cell Biol., 1, 199-207.
42. Ortt,K. and Sinha,S. (2006) Derivation of the consensus DNA-bindinf sequence for p63 reveals unique requirements that are distinct from p53. FEBS Letters, 580, 4544-4550.
43. Osada,M., Park.H.L. Nagakawa,Y., Yamashita,K., Fomenkov,A., Kim,M.S., Wu,G.I., Nomoto,S., Trink,B. and Sidransky,D. (2005) Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell. Biol., 25, 6077-6089.
44. Dietz,S., Rother,K., Bamberger,C., Schmale,H., Mössner,J. and Engeland,K. (2002) Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett., 525, 93-99.
45. Yu,J., Zhang,L., Hwang,P.M., Rago,C., Kinzler,K.W. and Vogelstein,B. (1999) Identitication and classitication ot p53-regulated genes. Proc. Natl Acad. Sci. USA, 96, 14517-14522.
46. Hagiwara,K., McMenamin,M.G., Miura,K. and Harris,C.C. (1999) Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res., 59, 4165-4169.
47. Yoshikawa,H., Nagashima,M., Khan,M.A., McMenamin,M.G., Hagiwara,K. and Harris,C.C. (1999) Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene, 18, 3415-3421.
48. Haugwitz,U., Wasner,M., Wiedmann,M., Spiesbach,K., Rother,K., Mössner,J. and Engeland,K. (2002) A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites. Nucleic Acids Res., 30,
49. Bressac,B., Galvin,K.M., Liang,T.J., Isselbacher,K.J., Wands,J.R. and Ozturk,M. (1990) Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl Acad. Sci. USA, 87, 1973-1977.
50. Krause,K., Wasner.M., Reinhard,W., Haugwitz,U., Lange-zu Dohna,C., Mössner,J. and Engeland,K. (2000) The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res., 28 4410-4418.
51. Wasner,M., Haugwitz,U., Reinhard,W., Tschöp,K., Spiesbach,K., Lorenz,J., Mössner,J. and Engeland,K. (2003) Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter. Gene, 312, 225-237.
52. Wasner,M., Tschöp,K., Spiesbach,K., Haugwitz,U., Johne,C., Mössner,J., Mantovani,R. and Engleand,K. (2003) Cyclin B1 during the cell cycle by a CHR-dependent repression mechanism. FEBS Lett., 536, 66-70.
53. Contente,A., Dittmer,A., Koch,M.C., Roth,J. and Dobbelstein,M. (2000) A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat. Genet., 30, 315-320.
54. Boyd,K.E., Wells,J., Gutman,J., Bartley,S.M. and Farnham,P.J. (1998) c-Myc target gene specificity is determined by a post-DNA binding mechanism. Proc. Natl Acad. Sci. USA, 95, 13887-13892.
55. Spiesbach,K., Tannapfel,A., Mössner,J. and Engleland,K. (2005) TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor. Int. J. Cancer, 114, 555-562.
56. el-Deiry,W.S., Kern,S.E., Pietenpol,J.A., Kinzler,K.W. and Vogelstein,B. (1992) Definition of a consensus binding site for p53. Nat. Genet. 1, 45-49.
57. Hupp,T.R., Meek,D.W., Midgley,C.A. and Lane,D.P. (1992) Regulation of the specific DNA-binding function of P53. Cell, 71, 875-886.
58. van Bokhoven,H. and Brunner,H.G. (2000) Splitting p63. Am. J. Hum. Genet., 71, 1-13.
59. Petitjean,A., Cavard,C., Shi,H., Tribollet,V., Hainaut,P. and Caron,d.F. (2005) The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Oncogene, 24, 512-519.
60. Mills,A.A. (2006) p63: Oncogene or tumor suppressor? Curr. Opin. Genet. Dev., 16, 38-44.
61. Yang,A., Zhu,Z., Kapranov,P., McKeon,F., Church,G.M., Gingeras,T.K. and Struhl,K. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol. Cell, 24, 593-602.
62. Ianakiev,P., Kilpatrick,M.W., Toudjarska,I., Basel,D., Beighton,P. and Tsipouras,P. (2000) Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am. J. Hum. Genet., 67, 59-66.